INTERACTIVE DISCUSSION GROUPS

(13.50 – 14.15 & 14.20 – 14.45) Interactive roundtable discussions, each 25 mins in duration, so attendees can choose 2 of the following topics:

1. Listening to, understanding, and hearing the patient voice

*Session organised by HSJ in collaboration with AbbVie*

Shared decision-making and patient choice – what does this mean for patients and for clinicians and what opportunities exist for strengthening it in the forthcoming Cancer Strategy? With services stretched, how can we ensure best practice is implemented whilst also acknowledging the diverse range of needs for the those living with cancer?

Moderators: Charlotte Crowley, Policy & Evidence Manger, Leukaemia Care & William Greenhill, Senior Government Affairs Manager, AbbVie

2. Cancer Alliance & ICB co-working and alignment – what does this look like in an ideal world?

*Session organised by HSJ in collaboration with Bayer*

How can Cancer Alliances and ICBs optimise the way they work together? How do we move beyond Cancer Alliances simply advising ICBs on services, and ICBs providing the resources? This session will look at a whole of range ways in which the two organisations can cooperate, from strategic long term planning, service design, commissioning, operational performance, whole-system delivery, clinical expertise (right place, right time), and ensuring both access the right funding, support and guidance from the centre.

Moderators: Sunita Berry, Managing Director, Peninsula Cancer Alliance & Simba Mavhunga, Senior Medical Advisor – Cardiology & Digital Health, Bayer

3. What role will genomics play in meeting ambitions for the future of cancer care?

* This discussion group is sponsored by Daiichi Sankyo and developed in collaboration with HSJ. Daiichi Sankyo has provided financial sponsorship for the HSJ Cancer Forum but has no role in the wider agenda *

Cancer genomics has the potential to revolutionise patient care and cement the UK’s role as a global leader in precision oncology. This discussion will consider:

- What innovations have defined the past decade?

- How can we turn ambition into action, and integrate genomics into routine practice to make a lasting impact on patients and the healthcare system?

- What role should genomics play in the government’s 10-year cancer plan?

- What are the key barriers to unlocking the potential of genomics? How can we solve these?

Moderators:

Nirupa Murugaesu, Consultant in Medical Oncology, Guy’s & St Thomas’ NHS Foundation Trust

Katie Snape, Lead Consultant for Cancer Genetics, South West Thames Centre for Genomics, St George’s University Hospitals NHS Foundation Trust and Chair, UK Cancer Genetics Group

4. Tackling lung cancer inequalities

*Session organised by HSJ in collaboration with BMS*

There are clear inequalities in the treatment of lung cancer, from screening and diagnosis, access, treatment, and survival outcomes. How do we address these challenges, how do we ensure sufficient capacity both locally and within the system, and how can data be leveraged more effectively to inform solutions and strategies.

Moderator: Jyotika Singh, Senior Principal Consultant, HSJ

5. The rise of supportive oncology

We will look at the changing role of palliative care in support of cancer patients through longer prognoses and a greater range of treatment, not just cancer side effects? How can we create a positive environment for palliative and end of life care for cancer patients? What does ‘good’ look like? We’ll look at service requirements, optimising commissioning frameworks, and rethinking patient pathways.

Moderator: Jennifer Vidrine, Consultant in Palliative Medicine, Newcastle Hospitals NHS Foundation Trust

6. Breast cancer pathway redesign – prescribing, treatment choices, and capacity optimisation

*Session organised by HSJ in collaboration with Lilly*

New adjuvant treatments for early breast cancer are good news for patients, however they also bring increased demand on clinical resources in breast cancer services. This session will explore how to design and implement an innovative, centralised service for patients with early breast cancer utilising digital health integration, service planning tools, and innovative workforce solutions, whilst maintaining a patient-centric approach.

Moderator: Dhalvir Midda, Head of Pharmacy – Cancer & Technical Services, Maidstone & Tunbridge Wells NHS Foundation Trust

7. Unlocking better cancer outcomes: the key role of cardiovascular health

*Session organised by HSJ in collaboration with Accord*

This session will explore how cardiovascular health can be optimised for cancer patients, given the development of increasingly powerful therapies which improve cancer survival but at the cost of CV toxicity. We will use examples from elderly patients with prostate cancer, but many of the learnings can be applied to other therapy areas. We will look at identifying at-risk patients, raising awareness of CV health in oncology teams, and interdisciplinary working models.

Moderator: Siva Tharshini Ramalingam, Cardio-Oncologist, The Royal Brompton Hospital & GP Partner, Oxted Health Centre

8. How mapping the cancer care pathway drives more effective service redesign

*Non-promotional session organised and funded by Novartis Pharmaceuticals UK Ltd in relation to a Collaborative Working Project with Belfast Health and Social Care Trust and Belfast City Hospital. For UK HCPs and Other Relevant Decision Makers*

NHS cancer services are under increasing pressures across the UK. With limited additional resources becoming available and the arrival of more innovative and complex treatments, there needs to be a fundamental rethink on how many of these services are designed to ensure they are future-fit. This session will showcase Collaborative Working Project from Belfast HSCT, where pathway mapping within the breast cancer service uncovered hidden blocks within the system. The oncology nurse specialist from Belfast will discuss with attendees how the outcomes resulted in a mindset shift on where pathway efficiencies needed to be made to make the greatest impact on the service overall. Attendees will gain:

- first-hand insights into how pathway mapping can reveal unseen challenges

- practical strategies for identifying and addressing inefficiencies in cancer services

- inspiration and actionable ideas to take back to their own healthcare settings

Moderator: Edel Aughey, Consultant Oncology Nurse Specialist, Belfast Health and Social Care Trust